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A B S T R A C T   
Background: The increased risk of mortality during periods of high and low temperatures has been well estab-
lished. However, most of the studies used daily counts of deaths or hospitalisations as health outcomes, although 
they are the ones at the top of the health impact pyramid reflecting only a limited proportion of patients with the 
most severe cases. 
Objectives: This study evaluates the relationship between short-term exposure to the daily mean temperature and 
medication prescribed for the respiratory system in five Spanish cities. 
Methods: We fitted time series regression models to cause-specific medical prescriptions, including different 
respiratory subgroups and age groups. We included a distributed lag non-linear model with lags up to 14 days for 
daily mean temperature. City-specific associations were summarised as overall-cumulative exposure-response 
curves. 
Results: We found a positive association between cause-specific medical prescriptions and daily mean tempera-
ture with a non-linear inverted J- or V-shaped relationship in most cities. Between 0.3% and 0.6% of all respi-
ratory prescriptions were attributed to cold for Madrid, Zaragoza and Pamplona, while in cities with only cold 
effects the attributable fractions were estimated as 19.2% for Murcia and 13.5% for Santander. Heat effects in 
Madrid, Zaragoza and Pamplona showed higher fractions between 8.7% and 17.2%. The estimated costs are in 
general higher for heat effects, showing annual values ranging between €191,905 and €311,076 for heat per 
100,000 persons. 
Conclusions: This study provides novel evidence of the effects of the thermal environment on the prescription of 
medication for respiratory disorders in Spain, showing that low and high temperatures lead to an increase in the 
number of such prescriptions. The consumption of medication can reflect exposure to the environment with a 
lesser degree of severity in terms of morbidity.   
1. Introduction 
The effects of the thermal environment on human health are well 
known and one of the most critical public health issues related to global 
climate change. The increase in the risk of mortality and hospital ad-
missions during periods of high and low temperatures has been well 
established (Gasparrini et al., 2015, 2017; Guo et al., 2017; Iñiguez 
et al., 2021; Song et al., 2017; Ye et al., 2012). Particularly, respiratory 
diseases are among the leading causes of death and disability in the 
world (Ferkol and Schraufnagel, 2014). Additionally, acute respiratory 
symptoms are among the health effects resulting from exposure to air 
pollution, and pollen is the largest reported cause of seasonal allergic 
rhinoconjunctivitis (SAR) (Zhao et al., 2019; Caillaud et al., 2015; 
Menichini and Mudu, 2010). 
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However, most of the studies used daily counts of deaths or hospi-
talisations as health outcomes, which are the ones at the top of the 
health impact pyramid and reflect only a limited proportion of patients 
with the most severe cases. Moreover, these health outcomes are not 
sufficiently sensitive to detect problems such as discomfort or effects on 
well-being (Royé et al., 2018; Gestal et al., 2020). Few studies have 
medical prescriptions as an outcome variable, and most of them are 
focused on air pollution or antiallergic drug consumption (Caillaud 
et al., 2015; Menichini and Mudu, 2010; Royé et al., 2018; Fuhrman 
et al., 2007; Matzarakis et al., 2008; Motreff et al., 2014; Hollingworth 
et al., 2016). 
The use of low-severity morbidity data would reach broader popu-
lation segments or be a more representative quantification of the 
morbidity associated with exposure to the environment. Preventive 
measures at this level could reduce the population’s vulnerability to 
more severe consequences, and become more effective in both the short 
and the long term. Hence, a deeper knowledge of thermal effects at the 
lower levels of this pyramid could be extremely useful for public health. 
It is therefore essential to use other health indicators such as over-the- 
counter (OTC) drug sales or medical prescriptions (Hollingworth 
et al., 2016). This kind of health indicator could even potentially iden-
tify and anticipate, among others, influenza outbreaks due to a more 
sensitive degree of the data source (Royé et al., 2018). 
This study aims to evaluate the relationship between short-term 
exposure to daily mean temperature and prescribed medications for 
the respiratory system in five Spanish cities with different climatic, so-
cioeconomic and populational characteristics. To our knowledge, this 
approach has never been used before to measure a relationship of this 
kind with figures for medical prescriptions in Europe. 
2. Methods 
2.1. Setting 
This study was carried out in the cities of Madrid, Murcia, Pamplona, 
Santander and Zaragoza, with populations that ranged from 3,182,981 
inhabitants (Madrid) to 171,951 (Santanderr) in 2017 (Fig. 1). Of the 
total population, only around 20% are older than 64 years of age. Due to 
their geographical location, we find different climatic conditions, from a 
humid oceanic climate in Santander to a Mediterranean coast and inland 
climate with dry and hot summers in Murcia or Zaragoza. 
2.2. Data sources 
2.2.1. Meteorological and air pollution data 
The meteorological data was obtained from the State Meteorological 
Agency (AEMET), which was accessed by using the OpenData API. Daily 
mean temperatures were collected from the weather station closest to 
each of the cities for the period between the years 2004 and 2018. To 
control for potential effects of air pollution, in the absence of quality 
contamination data covering the entire study period, we used the CAMS 
reanalysis data on atmospheric composition from the European Centre 
for Medium-Range Weather Forecasts (ECMWF) (Inness et al., 2019). 
For each city, the nearest reanalysis point (to the centre of the raster 
cells) of three-hourly PM10 concentrations was extracted. Then the 
average daily concentration was calculated. To prevent the potential 
influence of model outliers, we cut the daily time series of PM10 off at a 
threshold of 150 g/m3. 
2.2.2. Medical prescription data 
Medical prescriptions (both electronic and conventional) of the 
Anatomical Therapeutic Chemical (ATC) Classification System, group R, 
Fig. 1. Locations of the cities studied with population coverage and mean temperature.  
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were provided by the Spanish Agency for Medicines and Health Products 
for the study period between the years 2004 and 2018 for the cities of 
Madrid, Pamplona, Santander and Zaragoza. For the city of Murcia, 
however, the study period started in 2005 due to lack of availability of 
data for the previous year. The individual patient registers came from 
the Database for Pharmacoepidemiological Research in Primary Care 
(BIFAP) (Salvador Rosa et al., 2002). The BIFAP database currently 
collects data from seven autonomous communities, although Madrid 
and Cantabria participate only partially; in both regions data come from 
primary care physicians who collaborate in the database on a voluntary 
basis. We included those capitals as being representative of the different 
climates in Spain (Atlantic, Continental and Mediterranean). The pop-
ulation coverage in the BIFAP database is 94% in Pamplona, 100% in 
Zaragoza and Murcia, and 21% and 18% in Santander and Madrid, 
respectively. More specifically, the total daily number of prescriptions 
for medication for the following ATC groups were collected: main group 
R01-07 (respiratory system), subgroups R01-02 (nasal and throat 
preparations), R03 (drugs for obstructive airway diseases), R05 (cough 
and cold preparations) and R06 (antihistamines for systemic use). In 
addition, we created three age groups (<15, 15–64, >64) for the 
age-specific analysis. The subgroup of drugs for obstructive airway 
diseases (R03) was expected to be less sensitive to daily variations in 
ambient temperature given that it includes drugs for chronic conditions 
(such as chronic obstructive pulmonary disease (COPD)), which are 
routinely dispensed in accordance with a previously fixed schedule. The 
Spanish National Health System covers practically the entire population. 
We also obtained the monthly lists of the recommended retail prices of 
all the medications from the Spanish Ministry of Health so as to be able 
to estimate the costs attributable to heat and cold. 
2.2.3. Other data 
The monthly number of affiliates to the Spanish Social Security 
System (SS) was obtained from the Spanish Ministry of Inclusion, Social 
Security and Migrations to control for possible socioeconomic effects on 
medical prescriptions, as the reference population underwent changes 
particularly during the financial crisis (2008–2012) in Spain (see 
Figure S1). 
2.3. Statistical analysis 
We fitted a standard time-series quasi-Poisson regression using 
distributed lag non-linear models (DLNM) to estimate the associations 
between daily mean temperature and each respiratory-related pre-
scription (Gasparrinia et al., 2010). 
The model included the monthly number of affiliates to the SS as an 
offset, a natural cubic spline of time with 7 degrees of freedom per year 
to control for long-term trend and seasonality, dummy variables for day 
of the week, public holidays and influenza epidemics, the daily PM10 
level to control for time-varying confounders, and temperature. 
Air pollution and mean temperature were modelled by means of a 
constrained DLNM, using a natural cubic spline with three internal knots 
placed at equally spaced values in the log scale as a lag-response curve. 
Seven and 14 days were considered the maximum lag, for PM10 and 
temperature, respectively. The exposure-response curve for PM10 was 
modelled with a natural spline with two internal knots at the 90th and 
50th percentiles of the air pollutant distribution in the city. The 
exposure-response curve for temperature was modelled with a natural 
spline with internal knots placed at the 10th, 75th and 90th percentiles 
of city-specific temperature distributions. All of these specifications 
were widely accepted in the case of temperature. In the case of PM10, the 
non-linear exposure-response relationship was preferred to the linear 
specification based on the quasi-likelihood version of the Akaike Infor-
mation Criterion (AIC). 
For each outcome and exposure indicator, the temperature of mini-
mum morbidity (TMM) limited to the range of the 1–99th percentiles 
effect was calculated. Here this refers to medical prescriptions and is 
used as a reference to estimate the overall cumulative relative rate of 
prescription associated with cold and heat, respectively, defined as the 
risk increment at the 5th and 95th percentiles of the temperature dis-
tribution. Effect estimates are reported as Relative Risks (RR), with their 
95% confidence intervals (95%CI). The lagged pattern of associations 
for cold and heat were also examined in all cases. Finally, we calculated 
the attributable fractions (AF) and the annual attributable costs (AC) per 
100,000 inhabitants due to cold and heat from all the days of a tem-
perature below and above the TMM (Gasparrini and Leone, 2014). 
Statistical analyses were performed in R software (version 4.0.3), using 
the libraries DLNM 2.4.2. 
Some sensitivity and additional analyses were performed: 1) 5 and 
10 degrees of freedom for the time trend were also tested; 2) in order to 
test the possible artefactual of some extreme MMT locations, some 
ranges narrower than 1–99th centiles were tested; 3) the analysis was 
repeated without controlling for air pollution and, lastly, 4) the analysis 
was also performed by age group. 
3. Results 
The cities included in the study are characterised by different cli-
mates and socioeconomic features. Tables 1-2 show summary statistics 
of the meteorological variables and medical prescriptions. During the 
study period, there were 30, 332, 610 medical prescriptions attributed 
to respiratory causes in the five Spanish cities. Figure S2 shows the time 
trends of the total number of respiratory medications prescribed. A high 
seasonality and weekly pattern are highlighted, with considerably more 
prescriptions during winter periods (Figure S3). It is also notable that the 
number was close to zero at weekends and on holidays because primary 
care centres were closed, although some medication was still prescribed 
by emergency services (Figure S4). The magnitude of the main respi-
ratory drug prescriptions ranged between a daily maximum of 129 per 
10,000 inhabitants, with 44.2 being the mean value in Santander, and a 
maximum of 82.8 with a mean value of 31.1 in Pamplona (Table 2). 
The distribution of subclasses R01-02 to R06 of each city by month 
revealed the highest contribution, aside from the observed seasonality in 
the subclasses, in therapeutic group R03, drugs for obstructive airway 
diseases (Figure S3). The minimum number of all medical prescriptions 
is reached in August in all the cities. However, in the summer months the 
proportion of R03 is the highest. Subgroup R06, antihistamines for 
systemic use, reached its highest number of prescriptions in May and 
June, coinciding with the period of the highest pollen concentration. 
Cough and cold preparations (R05), as expected, showed the largest 
numbers in the winter months. 
Nasal and throat preparations (R01-02), however, showed no sea-
sonal patterns in medical prescriptions. The case distribution by age was 
highly variable in the respiratory subgroups in and between cites, 
ranging between 41 years for Murcia in R05 and 68 years for Madrid in 
R03. However, older patients are distinctly visible in the R03 group 
compared to the others (Table 2, Figure S5). 
The city-specific overall cumulative exposure-response association 
between total prescriptions and daily mean temperature was in general a 
non-linear inverted J- or V-shaped increase (Fig. 2). The exposure- 
response was V-shaped for Madrid, Pamplona and Zaragoza, 
evidencing clear heat and cold effects. It seems that the exposure- 
Table 1 
Descriptive statistics of daily mean temperature, 2004–2018.  
City Mean temperature (◦C) 
Max Mean Min P5% P95% 
Madrid 31.7 15.1 − 2.7 3.8 27.7 
Murcia 34.6 18.9 1.4 8.8 28.9 
Pamplona 31.6 13.3 − 5.2 2.8 24.7 
Santander 28.0 14.9 1.1 7.1 22.0 
Zaragoza 33.8 16.1 − 4.2 4.4 28.1  
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response curve stabilises as of a certain temperature threshold, for 
instance, in Madrid at 20 ◦C. While, for the other two cities, Murcia and 
Santander, the effect was seen to be limited only to cold. 
For nasal and throat preparations (R01-02), we observed cold effects 
in all cities and also a clear association with high temperatures in 
Madrid, Pamplona and Zaragoza (Fig. 3). As expected, in the subgroup 
of drugs for obstructive airway diseases (R03) effects were of lower 
magnitude but statistically significant for heat in Madrid and Murcia. 
Cough and cold preparations (R05) showed a similar pattern to R01-02. 
Finally, the association found in prescriptions of antihistamines for 
systemic use (R06) was limited to high temperatures, particularly visible 
in Madrid, Pamplona and Zaragoza. In Pamplona and Zaragoza, a slight 
effect of cold and some stabilisation at high temperatures were appre-
ciated. Santander, a small coastal city, showed the weakest association 
Table 2 
Daily statistics of medical prescriptions per 10,000 inhabitants with respect to the coverage for the respiratory group and subgroups between 2004 and 2018.  
City ATC Maximum Mean P5% P95% Total Median age 
Madrid R 86.7 25.4 0.6 52.5 7,723,787 59 
R01 13.8 2.7 0.0 6.6 845,024 48 
R03 30.8 10.6 0.1 22.1 3,333,808 68 
R05 35.8 4.5 0.0 18.4 1,407,500 57 
R06 43.0 6.8 0.0 19.3 213,7111 49 
Murcia* R 118.2 33.1 1.9 73.5 7,315,452 50 
R01 12.6 3.4 0.1 8.0 755,608 43 
R03 40.0 11.9 1.1 24.6 2,643,783 62 
R05 66.6 7.8 0.0 32.4 1,719,983 41 
R06 41.5 9.9 0.6 22.9 2,196,077 46 
Pamplona R 82.8 31.1 4.2 56.1 3,146,052 56 
R01 17.1 4.0 0.3 9.2 401,006 46 
R03 31.5 11.6 1.3 20.4 1,176,221 65 
R05 37.2 8.9 0.8 21.5 896,420 56 
R06 38.2 6.6 0.8 16.1 672,111 45 
Santander R 129.0 44.2 1.1 86.7 873,473 57 
R01 18.6 4.5 0.0 10.1 92,133 49 
R03 55.4 19.4 0.0 38.2 396,802 61 
R05 72.4 11.1 0.0 33.7 230,801 58 
R06 29.2 7.5 0.0 16.4 153,737 48 
Zaragoza R 102 31.0 0.3 67.5 11,273,846 56 
R01 18.4 4.0 0.0 10.4 1,454,740 46 
R03 40.0 11.0 0.1 26.9 4,022,448 66 
R05 51.2 8.2 0 26.7 2,997,729 49 
R06 42.5 7.7 0 21.8 2,798,892 50 
*period 2005–2018; coverage 100% Zaragoza and Murcia, 94% in Pamplona, 21% Santander and 18% in Madrid; R: respiratory system, R01-02: nasal and throat 
preparations, R03: drugs for obstructive airway diseases, R05: cough and cold preparations, R06: antihistamines for systemic use. 
Fig. 2. City-specific overall cumulative exposure-response relationships between mean temperature and respiratory prescriptions. Dashed vertical line is the min-
imum morbidity temperature. 
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with temperature, only restricted to cold effects for all subgroups. 
Regarding sensitivity and additional analyses, our results showed 
little sensitivity to the changes in the degrees of freedom of the time 
trend and to stronger restrictions in the range of percentiles allowed for 
the MMT location. The role of PM10 as a potential confounder was also of 
a small magnitude, in spite of its statistical significance in the model as 
an explanatory variable in some cases. 
The effect analysis by age groups revealed a similar pattern in gen-
eral (Figure S6-8). However, the greatest risks have been detected in 
those under 15 years of age with respect to the respiratory subgroups 
that were analysed (Figure S2). It is particularly remarkable that the 
oldest group (>64 years) showed the least cold and heat effects. For 
instance, in Madrid the RR with cold effects in respiratory prescriptions 
is 1.11 (1.04; 1.19) for <15 years, 1.01 (0.99; 1.03) for 15–64 years and 
1.01 (0.98; 1.04) for >64 years. But it could also be observed that the 
middle age group (15–64) in some cases showed the highest RR; in 
Zaragoza, for example, the estimated risks are the following: 1.25 (1.14; 
1.36) for <15, 1.30 (1.17; 1.44) for 15–64 and 1.06 (0.95; 1.19) for >64 
years. Finally, we found an association for the age group below the age 
of 15 years in the R03 subgroup (drugs for obstructive airway diseases). 
The MMT (Table S1) ranged between 5.1 ◦C and 7.5 ◦C for cities with 
cold and heat effects (Madrid, Pamplona and Zaragoza), and was esti-
mated with cold only at 24.2 ◦C and 30.8 ◦C for Santander and Murcia, 
respectively. The MMT for the respiratory prescription subgroups 
showed similar values with some remarkable changes. For instance, in 
the R06 group (prescriptions of antihistamines for systemic use) for 
Pamplona and Murcia, we observed a lower MMT of only 4.4 ◦C and 
9.7 ◦C, respectively. Regarding the patterns found in the age groups, we 
could only observe that, in general, the MMT seemed to tend to be 
higher for the youngest age group. 
Table 3 shows the excess of medical prescriptions and costs attrib-
utable to heat and cold by city and ATC group. Between 0.3% and 0.6% 
of all respiratory prescriptions were attributed to cold for Madrid, Zar-
agoza and Pamplona. In cities with effects only due to cold, the attrib-
utable fractions (AF) were estimated as 19.2% for Murcia and 13.5% for 
Santander. Heat effects in Madrid, Zaragoza and Pamplona showed 
higher AFs of between 8.7% and 17.2%. The estimated attributions were 
similar in the respiratory subgroups but with apparent singularities in 
Fig. 3. City-specific overall cumulative exposure-response relationships between mean temperature and subgroups of respiratory prescriptions. Dashed vertical line 
is the minimum morbidity temperature. 
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coherence with the relationship found for the subgroups. For instance, 
Madrid had significant high effects in all the subgroups analysed. The 
estimated costs were in general higher for heat effects, showing annual 
values ranging between €191,905 and €311,076 for heat and between 
€5870 and €13,253 per 100,000 persons for cold in Madrid, Pamplona 
and Zaragoza for the total respiratory group. An important subgroup of 
respiratory prescriptions is R06, antihistamines for systemic use, where 
annual costs of between €32,708 and €56,788 per 100,000 persons were 
estimated. 
Table 4 summarises the fraction of medical prescriptions attributable 
to heat and cold by respiratory subgroup and age group. In coherence 
with the above, the AFs are higher for those under 15 years of age in all 
the cities and subgroups analysed. In heat effects, the highest AFs are 
observed over all age groups in R06 (antihistamines for systemic use) 
ranging between 7.7% and 42%, with absence of any effect in the case of 
Santander. Regarding the effect of cold, the pattern is different, showing 
great AFs in subgroups R05 (Cough and cold preparations) and R01-02 
(Nasal and throat preparations). 
Figure S9 shows the lag structure of the overall cumulative heat- and 
cold-related effects of mean temperature on respiratory medical de-
scriptions. Heat effects persisted in a decreasing manner up to a lag of 
4–5 days. Longer lagged effects, in general, were observed for low 
temperatures with lags from 8 days onwards, although in Madrid and 
Zaragoza there are particularly significant cold effects from the first lag 
to the third. The lag structure for specific respiratory subgroups and age 
groups showed a similar pattern (Figures S10-S13). 
4. Discussion 
The study found evidence that daily medical prescriptions for res-
piratory use are associated with mean temperature in all the cities 
analysed. However, there are essential differences in the magnitude, 
shape and lag structure among cities, age groups and ATC subgroups, 
which could be related to city-specific climatic, socioeconomic and de-
mographic factors. 
In antihistamines for systemic use (R06), the estimated heat effects 
could be related to the seasonal relationship with the presence of al-
lergens, which could partially explain why the exposure-response curve 
reaches stability as of a temperature of approximately 20 ◦C. Pollen is 
the second most frequent allergen, and the majority of the most aller-
genic species bloom in spring (e.g. banana trees, olive trees, grasses). But 
it must be taken into account that house dust mites are the main aller-
gens in Spain. Since citizens tend to spend more time outdoors in sum-
mer, this could reduce exposure. In the case of Madrid, the consumption 
of antihistamines with high temperature could be attributed to other 
allergens and an extended pollen season or other pollutants (Kani-
kowska et al., 2018; Damialis et al., 2019). 
Although we have not specifically controlled for pollen concentra-
tions, it can be considered that they are partially introduced by the PM10 
(Anenberg et al., 2020). The explanation of the heat-related effects on 
antihistamines might lie in an interactive mechanism between hot 
temperatures and levels of PM10 (Analitis et al., 2018). In spite of the 
Table 3 
Estimation of fraction and related costs attributable to heat and cold for respi-
ratory prescriptions by city and ATC subgroup.  
City ATC Attributable Fraction, 
AF% (95% CI) 
Annual attributable Costs per 
100,000 person, € (95% CI) 
Cold Heat Cold Heat 
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270 (85; 442)  
Table 3 (continued ) 
City ATC Attributable Fraction, 
AF% (95% CI) 
Annual attributable Costs per 
100,000 person, € (95% CI) 









388 (37; 719) 50,551 
(43,913; 
56,415) 
R: Respiratory system; R01-02: Nasal and throat preparations; R03: Drugs for 
obstructive airway diseases; R05: Cough and cold preparations; R06: Antihis-
tamines for systemic use. 
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statistical significance of PM10, in some cases (assessed by the LR test), 
which proves its role as an outcome predictor, the magnitude of con-
founding caused by PM10 was very small, in fact almost inexistent in 
most of the cities analysed. 
Likewise, exposure to tropospheric ozone has been related to 
symptoms similar to those produced by allergies (Sheffield et al., 2015; 
Lee et al., 2013). Furthermore, this compound reaches its maximum 
levels in spring in coastal regions, but in summer in inland regions 
(Santurtún et al., 2015), which could also partly explain the results 
found in Madrid. The geographic location could also explain the lower 
effects observed in Santander, on the Atlantic coast, where the pollen 
concentration is usually lower. In this context, the heat effects observed 
in the case of nasal and throat preparations (R01-02) could be related to 
the therapeutic use of some medicines, such as decongestants for nasal 
congestion due to allergies. 
The mainly low and constant risks found in the subgroup of drugs for 
obstructive airway diseases (R03) were expected, as we used it as a 
control group, and can be explained by the fact that this group is mostly 
made up of patients with chronic conditions, such as chronic obstructive 
pulmonary disease (COPD), who have a basal consumption. Potential 
decompensation of COPD patients is usually associated with infections 
such as pneumonia treated with other medical therapeutic groups 
(Restrepo et al., 2018). Nevertheless, it is necessary to emphasise here a 
positive association with heat and cold effects found in those under the 
age of 15 years in the case of drugs for obstructive airway diseases, 
probably related to childhood asthma. In consequence, the effect found 
in all ages is due to the association in the younger age group. 
Many studies have reported U-shaped or J-shaped associations be-
tween temperature and mortality and morbidity (Gasparrini et al., 2015, 
2017; Guo et al., 2017; Gestal et al., 2020). Likewise, this study 
confirmed these findings for prescriptions for medication for respiratory 
conditions with increasing risks at low and high temperatures. Con-
trasting patterns of temperature-related mortality and morbidity 
depending on the city were found in previous studies (Iñiguez et al., 
2021; Song et al., 2017). For instance, heat was not found to have an 
impact on hospital admissions, and the estimated fraction of mortality 
attributable to cold was of greater magnitude in hospitalisations 
compared to deaths. In contrast to these findings, our results showed 
effects not only of cold but also of heat. 
From a physiological standpoint, the results obtained concerning 
respiratory prescriptions and mean temperature are coherent with the 
biological mechanisms put forward to explain how changes in the 
thermal environment increase respiratory disorders, in turn leading to 
higher numbers of medical prescriptions. The thermal environment af-
fects the respiratory system through indirect processes and direct 
physiological processes triggered in the body (D’Amato et al., 2018; 
Santurtún et al., 2017). Particularly, cold air causes bronchial inflam-
mation, which makes it easier to contract diseases via respiratory viruses 
(Eccles and Wilkinson, 2015). In the upper respiratory tract, it produces 
a decrease in the temperature of the respiratory epithelium with asso-
ciated lower mucociliary clearance, reduced blood flow and a local 
immune response, which favour respiratory tract infections and cold 
symptoms (Mourtzoukou and Falagas, 2007). 
There are no known direct physiological mechanisms that can 
explain the effect of heat on the respiratory tract. However, some of our 
results may be due to indirect mechanisms. Heat has been linked to 
cardiovascular disorders; high temperatures can damage blood vessels 
by interfering with nitric oxide synthesis, cytokine production and sys-
temic inflammation, and may promote thrombogenesis (Gostimirovic 
et al., 2020). Cardiovascular events are related to respiratory diseases. 
This is why a patient with a basal respiratory disease, exacerbations and 
greater consumptions of respiratory drugs can be expected to develop 
cardiovascular diseases (Carter et al., 2019). Moreover, subsequent 
cardiovascular episodes in some patients are followed by pneumonia, 
which may be another indirect link between respiratory and cardio-
vascular responses to high temperatures (Corrales-Medina et al., 2015). 
Due to the lack of studies on the relationship between medications 
and the thermal environment, a comparison with other research results 
reporting heat or cold effects as relative risks is extremely limited. 
However, the effect size observed is similar to that noted by Matzarakis 
et al. (2008), who reported on the thermal environment and pharma-
ceutical sales (non-prescription medicines for the common cold) for 
several German cities. In a recent study, Royé et al. (2018) found that 
low apparent temperatures proved to be associated with increased sales 
Table 4 
Fraction of respiratory prescriptions attributable to heat and cold by city, age group and ATC subgroup.   
Cold Heat 
City ATC <15 15–64 >64 <15 15–64 >64 
Madrid R 1.5 (0.5; 2.5) 0.2 (− 0.1; 0.5) 0.2 (− 0.2; 0.7) 25.4 (20.7; 29.8) 10.3 (5.1; 14.9) 10 (4.4; 14.8) 
R01-2 1.0 (− 0.1; 1.9) 0.3 (0.0; 0.7) 0.5 (− 0.1; 1.1) 29.2 (24.6; 33.2) 18.3 (11.1; 24.5) 12.9 (7.4; 17.7) 
R03 14.2 (− 10.5; 34.1) 0.4 (03.0; 0.7) 0.2 (− 0.2; 0.6) 18.5 (13.8; 22.9) 0.0 (0.0; 0.0) 8.8 (3.5; 13.9) 
R05 45.4 (7.8; 66.8) 32.7 (18.9; 43.5) 27.8 (16.4; 37.1) 0.5 (0.1; 0.7) 0.0 (0.0; 0.0) 0.2 (0; 0.5) 
R06 0.2 (− 0.1; 0.4) 0.0 (0.0; 0.0) 0.1 (− 0.2; 0.4) 42.0 (33.9; 49.1) 38.3 (33.1; 43.1) 16.5 (11.3; 21.3) 
Murcia R 69.1 (61.2; 75.3) 0.4 (0.1; 0.7) 10.6 (− 1.3; 20.5) 8.4 (4.1; 12.5) − 0.2 (− 0.3;-0.1) − 0.1 (− 0.1; 0.0) 
R01-2 83.3 (77.4; 87.5) 24.9 (9.5; 37.4) 26.8 (11.9; 39.4) 0.0 (− 0.1; 0.0) − 0.3 (− 0.5;-0.2) − 0.1 (− 0.2;-0.1) 
R03 71.8 (63.6; 78.0) 0.0 (− 0.1; 0.1) 0 (− 0.2; 0.2) 7.7 (2.1; 12.8) − 0.3 (− 0.4;-0.2) 7.2 (2.1; 11.8) 
R05 74.0 (65.0; 80.3) 36.8 (24.1; 46.9) 22.9 (6.5; 36) 0.1 (− 0.1; 0.2) − 0.1 (− 0.2;-0.1) 0.0 (− 0.1; 0.1) 
R06 56.2 (46.7; 64.1) 0.0 (0.0; 0.1) 10.7 (− 1.7; 21.1) 20.8 (14.8; 26.1) − 0.2 (− 0.3;-0.1) − 0.1 (− 0.1; 0.0) 
Pamplona R 41.6 (31.0; 50.9) 0.8 (0.5; 1.1) 0.1 (− 0.2; 0.4) 16.7 (13.2; 19.8) − 0.1 (− 0.2;-0.1) 4.6 (− 0.2; 9.1) 
R01-2 51.6 (33.2; 64.5) 0.9 (0.5; 1.3) 21.6 (7.9; 33.4) 16.7 (12.6; 20.6) − 0.2 (− 0.2;-0.1) 0.0 (− 0.1; 0.0) 
R03 46.4 (35.1; 55.3) 0.2 (− 0.2; 0.6) 0.0 (0.0; 0.0) 5.6 (0.4; 10.4) − 0.2 (− 0.3;-0.1) 4.2 (− 6.5; 13.7) 
R05 60.9 (50.1; 69.3) 32.2 (25.1; 38.5) 17.1 (9.2; 24) 0.4 (0.2; 0.7) − 0.2 (− 0.2;-0.1) 0.2 (0.0; 0.4) 
R06 0.2 (− 0.2; 0.6) 0.4 (0.2; 0.6) 0.1 (− 0.2; 0.5) 31.7 (28.3; 34.9) 26.5 (20.4; 32) 7.7 (2.2; 12.6) 
Santander R 27.3 (11.3; 40.4) 16.6 (2.1; 28.6) 4.9 (− 6.3; 14.6) 0.0 (− 0.2; 0.0) 0.0 (− 0.1; 0.1) 0.0 (− 0.3; 0.3) 
R01-2 40.5 (21.5; 53.7) 21.0 (1.1; 36) 12.5 (− 16.7; 34.1) 0.0 (− 0.2; 0.1) 1.1 (0.1; 1.7) 0.0 (− 0.2; 0.1) 
R03 26.9 (15.8; 36.4) 14.9 (− 0.7; 28.1) 5.2 (− 4.9; 14.2) − 0.1 (− 0.2; 0.0) 0.1 (− 0.3; 0.5) 0.1 (− 0.5; 0.6) 
R05 41.6 (15.7; 59.1) 21.6 (0.2; 37.9) 7.6 (− 16.8; 26.4) 0.0 (− 0.1; 0.1) − 0.2 (− 0.5; 0.0) 0.0 (− 0.2; 0.1) 
R06 34.0 (11.1; 50.7) 15.6 (− 0.9; 29.2) − 0.1 (− 0.1; 0.0) − 0.1 (− 0.2; 0.0) − 0.1 (− 0.3; 0.1) 14.9 (− 0.2; 27.2) 
Zaragoza R 35.2 (24.6; 44.1) 0.7 (0.4; 1.0) 0.3 (0.0; 0.7) 17.6 (14.3; 20.7) − 0.1 (− 0.1; 0.0) 6.5 (2.4; 10.2) 
R01-2 39.0 (25.4; 50.1) 0.7 (0.4; 1.0) 13.6 (2.5; 23.4) 17.4 (13.8; 20.7) − 0.1 (− 0.1; 0.0) 0.0 (0.0; 0.0) 
R03 40.2 (29.6; 49.0) 0.2 (− 0.1; 0.4) 0.0 (− 0.2; 0.2) 13.6 (9.4; 17.5) − 0.1 (− 0.1;-0.1) 5.3 (0.1; 9.9) 
R05 52.2 (41.9; 60.4) 38.6 (31.9; 44.7) 23.9 (15.7; 31.3) 0.4 (0.2; 0.6) 0.0 (− 0.1; 0.0) 0.4 (0.2; 0.6) 
R06 0.1 (− 0.2; 0.4) 0.1 (0.0; 0.3) 0.3 (0.0; 0.6) 32.9 (29.5; 36.2) 23.3 (17.7; 28.3) 11.4 (7.5; 15.1) 
R: Respiratory system; R01-02: Nasal and throat preparations; R03: Drugs for obstructive airway diseases; R05: Cough and cold preparations; R06: Antihistamines for 
systemic use. 
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of over-the-counter respiratory drugs in north-western Spain. In contrast 
to our results, no association with heat was estimated. 
The age characteristics found in this study reflect a younger popu-
lation than is commonly seen from other sources such as hospital ad-
missions or even in mortality. The results obtained by age groups 
revealed, in general, greater effects in the younger population than in 
those over 64 years old. This difference is likely to be due, on the one 
hand, to more chronic conditions and polymedicated elderly patients, 
who are treated and observed on a regular basis by their general prac-
titioner (Galán-Retamal et al., 2010; Xie et al., 2020). On the other hand, 
a small decrease in the diameter of the airway in children, due to a 
stimulus that produces hyperresponsiveness, has a greater impact on the 
air flow than in adults (Sunyer, 2008; Nhung et al., 2017). 
Temperature-related mortality is a premature consequence, although 
it affects a smaller proportion of the population than the possible effects 
of morbidity. In this regard, a measure of morbidity based on a lower 
degree of severity but a larger proportion of a population affected has 
certain advantages and drawbacks vis-à-vis the measuring of hospital 
admissions (Royé et al., 2018; Gestal et al., 2020). This assumption is 
confirmed in our study, since the heat and cold effects observed are 
found mainly in people under 64 years of age. 
We must highlight the advantages of using medical prescriptions, 
since the population included and affected is younger. Besides, it allows 
us to analyse the influence of temperature due to pathologies in an in-
direct way. To our knowledge, this approach has never been used before 
to measure a relationship of this nature with outcomes for medical 
prescription in Europe. However, some limitations should also be 
acknowledged. First, there is the delay in the event with respect to the 
date of the medical prescription, the dispensing of the drug and its 
corresponding consumption. However, this limitation was offset by the 
use of distributed lag models. Another drawback is that they may not 
correspond to those consumed by self-medication and non-compliance 
with therapy when using prescribed medicines. However, we do not 
believe that this biases the study results since both self-medication and 
therapeutic compliance should not be associated with ambient temper-
ature. Second, the database used does not include over-the-counter drug 
records, which means that we lose sensitivity with respect to the pop-
ulation affected by exposure to the environment. Another aspect is the 
database coverage for Madrid and Santander with 18% and 21%, 
respectively, which are low figures that could influence the statistical 
power of the model, particularly in Santander. The low coverage can 
also have impacts on results as the spatial distribution of participating 
primary care physicians might not be homogeneous. 
In conclusion, the results of the first study of the effects of the 
thermal environment on the prescription of medication for respiratory 
diseases in Spain from 2004 to 2018 provide new evidence that tem-
peratures lead to increased numbers of such prescriptions. The con-
sumption of medication can reflect exposure to the environment with a 
lesser degree of severity in terms of morbidity. The exposure-response 
curves of prescriptions for medication for respiratory ailments can 
show both heat and cold effects. 
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Salvador Rosa, A., Moreno Pérez, J.C., Sonegob, D., García Rodríguez, L.A., De Abajo 
Iglesias, F.J., 2002. The BIFAP project: database for pharmaco-epidemiological 
research in primary care. Atención Primaria 30 (10). https://doi.org/10.1016/ 
s0212-6567(02)79129-4. 
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